The association of c-reactive protein with arterial compliance in asymptomatic young adults: The bogalusa heart study

Journal of Human Hypertension

Volumn 27, Issue 4, 2013, Pages 256-260

  Sharma, D ^a   Dasmahapatra, P ^b   Fernandez, C ^b   Chen, W ^b   Srinivasan, S R ^b   Xu, J ^b   Berenson, G S ^b  

^a Rapides Regional Medical Center   (United States)

^b Tulane Center for Cardiovascular Health   (United States)

Author keywords

compliance; hsCRP; vascular

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN;

ADULT; ARTERY COMPLIANCE; ARTICLE; ATHEROGENESIS; BODY SURFACE; CARDIOVASCULAR EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AFRICAN AMERICANS; AGE FACTORS; ARTERIES; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMPLIANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LOUISIANA; MALE; MULTIVARIATE ANALYSIS; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84875219095     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.34     Document Type: Article

References (35)

1. Bassak SS, Rifai N, Ridker PM. High sensitivity C-reactive protein. Carr Probl Cardiol 2004; 29: 439-493.
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
3. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-2363.
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-428.
5. Van Der Meer IM, De Maat MP, Hak AE, Kiliaan AJ, Del Sol AI, Van Der Kuip DA et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke 2002; 33: 2750-2755.
6. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y et al. Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88: 112-117.
7. Fichtscherer S, Rosenberger G, Walter DH, Breuer S, Dimnieler S, Zeither AM. Elevated C-reactive protein and impaired endothelial vaso reactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-1006.
8. Abramson JL, Vaccarine V. Relationship between physical activity and inflammation among apparently healthy middle aged and older US adults. Arch Intern Med 2002; 162: 1286-1292.
9. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997; 10: 1175-1189.
10. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
11. Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001; 14: 258S-263S.
12. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26: 503-508.
13. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-rective protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
14. Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103: 1194-1197.
15. Berenson GS. Causation of cardiovascular risk factors in children. In: Taitz LS (ed). Perspectives on Cardiovascular Risk in Early Life. Raven Press: New York, NY, 1986, pp 1-408.
16. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC et al. Cardiovascular Risk Factors in Children. In: Andrews C, Hester HE (eds). The Early Natural History of Atherosclerosis and Essential Hypertension. Oxford University Press: New York, 1980, pp 47-123.
17. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. in: Lewis (ed). Handbook of Electrophoresis. CRC: Boca Raton, FL, 1883, pp 185-204.
18. Hypertension Diagnostics Inc. HDI/Pulsewave CR-2000 Research CardioVascular Profiling System Operators ManualEagan, Minn, Hypertension Diagnostic 1999.
19. Finkelstein SM, Cohn JN. First and third order models for determining arterial compliance. J Hypertens Suppl 1992; 10: 511-514.
20. Rietzchel ER, Boeykens E, De Buyzere ML, Duprez DA, Clement DL. A companion between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension 2001; 37: E15-E22.
21. Bhuiyan AR, Chen W, Srinivasan SR, Azevedo MJ, Berenson GS. Relationship of low birth weight to pulsatile arterial function in asymptomatic younger adults:the Bogalusa Heart Study. Am J Hypertens 2010; 23(2): 168-173.
22. Bhuiyan AR, Srinivasan SR, Chen W, Sultana A, Berenson GS. Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study. Metabolism 2008; 57(5): 612-616.
23. Bhuiyan AR, Li S, Li H, Chen W, Srinivasan SR, Berenson GS. Distribution and correlates of arterial compliance measures in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens 2005; 18(5 Prt 1): 684-691.
24. O'Rourke MF, Staessen JA, Viachopoulos C, Duprez DA, Plante GE. Clinical application of arterial stiffness; definition and reference values. Am J Hypertens 2002; 14: 426-444.
25. AHA/CDC Statement. Circulation 2003; 107: 499-511.
26. Ross R. Pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
27. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
28. Ridker PM. C-Reactive protein and the risks of future myocardial infarction and thrombotic stroke. Eur Heart J 1998; 19: 1-3.
29. Van Der Meer IM, De Maat MP, Hak AE, Kiliaan AJ, Del Sol AI, Van Der Kuip DA et al. C-reactive protein predicts the progression of atherosclerosis measures at various sites of the arterial tree: the Rotterdam Study. Stroke 2002; 33: 2750-2755.
30. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y et al. Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88: 112-117.
31. Mc Veigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (London) 2001; 100: 387-393.
32. Gilani M, Kaiser DR, Bratteli CW, Alinder C, Rajala S, Bank AJ et al. Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertension. J Am Soc Hypertens 2007; 1: 45-55.
33. Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
34. Waddell TK, Dart AM, Medley TL, Cameron JD, Kingwell BA. Carotid pressure is a better predictor of coronary artery disease severity that brachial pressure. Hypertension 2001; 38: 927-931.
35. The CAFÉ investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFÉ) study. Circulation 2006; 113: 1213-1225.